PADCEV plus Keytruda reduces bladder cancer recurrence risk by 47%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. ADYYF
9. WDAY
10. DVLT

Go back to PADCEV plus Keytruda reduces bladder cancer recurrence risk by 47%
Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) Delayed: 14.72 +0.18 (1.24%)
Previous Close $14.54    52 Week High $19.40 
Open $14.67    52 Week Low $12.50 
Day High $14.79    P/E N/A 
Day Low $14.34    EPS $0.00 
Volume 76,662       

Pfizer Inc. (NYSE: PFE) Delayed: 26.79 -0.01 (0.04%)
Previous Close $26.80    52 Week High $37.39 
Open $26.66    52 Week Low $28.25 
Day High $26.92    P/E 16.24 
Day Low $26.42    EPS $1.65 
Volume 23,170,261